Qingdao Baheal Medical Inc. (known as: Baheal Medical, Stock Code: 301015) was founded in 2005. As an industrialization platform with innovative brand-building capabilities, the company takes technological innovation as its core driving force and is committed to optimizing and upgrading medical scenarios. Its core business focuses on the full chain of development, manufacturing and commercialization of medical innovations.

Leveraging its technical capabilities in modern traditional Chinese medicine (TCM) ,  advanced controlled-release formulations, and radiosurgery, the company has built a comprehensive R&D and production system for both pharmaceuticals and medical devices, and continuously promotes the efficient translation of original innovative achievements into clinical products. We have launched a variety of innovative products with proprietary intellectual property rights, and consistently drive forward technological development and production for upstream medical innovations.

Through our well-established commercialization capabilities and extensive global sales and marketing network, Baheal Medical accelerates the rapid adoption of high-quality medical and health products in clinical practices. At present, we have established a diversified product matrix covering bone health, anti-organ fibrosis and brain metastases, boast a variety of innovative products with independent intellectual property rights, and incubated multiple category-leading brands.

Going forward, Baheal Medical will continue to uphold its mission of " Better Science, Better Health" and provide higher-quality, more accessible medical and health products and services to the whole society.